PLAT and stroke disorder: For ischemic (ie, nonbleeding) strokes, a blood-clot dissolving drug tissue plasminogen activator (tPA) greatly reduces the risk of severe disabilities if administered within 4 1⁄2 hours from the onset of stroke symptoms [4,5].